Will the advent of Molnupiravir in the COVID-19 treatment armamentarium be a game-changer? In this webinar on "Molnupiravir -An emergent strategy in the management of Covid -19" our expert will talk about the current scenario of COVID-19, the stepwise treatment approach, the importance of early antiviral therapy in COVID-19, benefits of molnupiravir, the clinical 3 trial data on molnupiravir and some important questions of dosage and usage of molnupiravir in COVID-19 treatment.
MBBS, Diploma in Tuberculosis and Chest Diseases (DTCD), MD - Tuberculosis & Respiratory Diseases, Medicine Pulmonologist
Dr. Prasanna Kumar is a MBBS, Diploma in Tuberculosis and Chest Diseases (DTCD), MD - (Tuberculosis & Respiratory Diseases, Medicine) and Senior Consultant Pulmonologist at Sri Ramachandra Medical College and MGM healthcare Hospitals at Chennai. He is a member of Tamilnadu Medical Council and Indian Medical Association (IMA).
MD (Chest), FRCP-LONDON ( UK), FCCP ( USA) FAMS ( INDIA) Prof & HOD of Pulmonary medicine SVS Medical Collage
Dr. Pradyut Waghray is a MD (Chest), FRCP-London ( UK),FCCP ( USA) FAMS (India), Prof & HOD of Pulmonary Medicine SVS, Medical College, Founder Chairman of the Kunal Institute of Medical Specialities Pvt Ltd Hyderabad and Senior Consultant Pulmonologist Apollo hospitals Hyderabad. He completed MBBS from Osmania Medical College, Hyderabad in 1982, Diploma in Tuberculosis and Chest Diseases (DTCD) from AP Chest Hospital, Hyderabad in 1984 and MD - Tuberculosis & Respiratory Diseases/Medicine from Osmania Medical College, Hyderabad in 1986. Dr. Pradyut Waghray was recently conferred with the fellowship of the academy of medical specialties by the Indian Medical Association. He is Member of the British thoracic society and also gold member of European respiratory society. Dr. Waghray has many publications and presentations to his credit.